Scientific Paper

The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques

April 27, 2023

The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques

Back to Resources

At Atuka, we combine our capabilities with yours to harness the power of partnership and advance your therapeutic program.

Talk to a Neuroscience Expert